Zelira Therapeutics Meets Primary Endpoints for Phase (1b/2a) Medicinal Cannabis Trial for Insomnia

PERTH, Australia, Feb. 18, 2020 /PRNewswire/ -- Teleconference 11am (AEDT) today with Osagie Imasogie, Zelira Chairman and Dr Richard Hopkins, Managing Director-ex USA Toll free dial‐in (Australia): 1800 908 299 Conference ID: 10004335 (more dial in options p4) Zelira Therapeutics Ltd...

from PR Newswire: https://ift.tt/2P7AFVn